A detailed history of Polar Capital Holdings PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Polar Capital Holdings PLC holds 99,212 shares of LLY stock, worth $87.9 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
99,212
Previous 118,443 16.24%
Holding current value
$87.9 Million
Previous $92.1 Million 2.52%
% of portfolio
0.55%
Previous 0.58%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $13.9 Million - $17.5 Million
-19,231 Reduced 16.24%
99,212 $89.8 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $4.68 Million - $6.26 Million
7,902 Added 7.15%
118,443 $92.1 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $4.99 Million - $5.89 Million
-9,509 Reduced 7.92%
110,541 $64.4 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $7.32 Million - $10.1 Million
-16,841 Reduced 12.3%
120,050 $64.5 Million
Q2 2023

Dec 13, 2023

SELL
$350.74 - $468.98 $646,063 - $863,861
-1,842 Reduced 1.33%
136,891 $64.2 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $646,063 - $863,861
-1,842 Reduced 1.33%
136,891 $64.2 Million
Q1 2023

Dec 13, 2023

BUY
$310.63 - $364.82 $5.8 Million - $6.82 Million
18,683 Added 15.56%
138,733 $47.6 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $4.14 Million - $4.86 Million
-13,320 Reduced 8.76%
138,733 $47.6 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $12.5 Million - $14.6 Million
38,915 Added 34.4%
152,053 $55.6 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $22 Million - $25.1 Million
74,144 Added 190.14%
113,138 $36.6 Million
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $1.74 Million - $2.05 Million
-6,254 Reduced 13.82%
38,994 $12.6 Million
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $420,564 - $522,654
-1,792 Reduced 3.81%
45,248 $13 Million
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $1.9 Million - $2.34 Million
8,588 Added 22.33%
47,040 $10.9 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $6.94 Million - $8.98 Million
38,452 New
38,452 $8.83 Million
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $10.7 Million - $13.8 Million
-64,908 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $8.47 Million - $11.2 Million
64,908 New
64,908 $11 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $842B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Polar Capital Holdings PLC Portfolio

Follow Polar Capital Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.